Treatment of community-associated methicillin-resistant Staphylococcus aureus infections

Pediatr Infect Dis J. 2005 May;24(5):457-8. doi: 10.1097/01.inf.0000164162.00163.9d.

Author

Sheldon L Kaplan¹

Affiliation

¹ Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.

PMID: 15876948
DOI: 10.1097/01.inf.0000164162.00163.9d

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Child
Child, Preschool
Clindamycin / therapeutic use*
Community-Acquired Infections / diagnosis
Community-Acquired Infections / drug therapy
Female
Follow-Up Studies
Humans
Male
Methicillin Resistance*
Microbial Sensitivity Tests
Risk Assessment
Staphylococcal Infections / diagnosis
Staphylococcal Infections / drug therapy*
Staphylococcus aureus / drug effects*
Staphylococcus aureus / isolation & purification
Treatment Outcome
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use*

Substances

Clindamycin
Trimethoprim, Sulfamethoxazole Drug Combination